S. Allaert , M. Bangia , K. Rans MD, C. Berghen MD, S. Joniau MD, PhD, G. Devos MD, H. Dumez MD, PhD, S. Jentjens MD, PhD, G. De Meerleer MD, PhD
SUMMARY
This case report of an 80-year-old patient, who presented with up to six manifestations of oligorecurrent prostate cancer (PCa) over a time period of nine years, shows that repeated treatment with metastasis directed therapy (MDT) in this setting is feasible and nearly atoxic.
